@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix hgnc: . @prefix proteinModification: . @prefix psimod: . @prefix go: . @prefix Protein: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:variantOf hgnc:11204; a proteinModification:, psimod:00696 . sub:_2 hasAgent: sub:_3; a go:0042789 . sub:_3 geneProductOf: hgnc:11204; a Protein: . sub:_4 occursIn: obo:UBERON_0002418, species:9606; rdf:object sub:_2; rdf:predicate belv:directlyIncreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:SOX9,pmod(P,S,181)) => tscript(p(HGNC:SOX9))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "To elucidate the effects of TGF signaling in chondrocytes at the level of active (phosphorylated) SOX9, we performed immunofluorescence experiments to detect SOX9 (pS181) in primary chondrocytes, with or without TGF treatment. Interestingly, SOX9 (pS181) levels were much lower after exposure to TGFalpha, being almost entirely abrogated after only 2 days of TGF treatment. from full text"; prov:wasQuotedFrom pubmed:17968906 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17968906; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:13.476+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }